Table 2.
Summary of adverse events
| AEs | A0.3/BPO2.5 side | Vehicle side | Not side specific | Total | ||||
|---|---|---|---|---|---|---|---|---|
| n | Subject | n | Subject | n | Subject | n | Subject | |
| All AEs | 20 | 14 (20.9) | 11 | 6 (9.0) | 125 | 42 (62.7) | 156 | 47 (70.1) |
| Treatment-related AEs | 16 | 14 (20.9) | 6 | 6 (9.0) | 9 | 5 (7.5) | 31 | 17 (25.4) |
| AEs leading to discontinuation | 2 | 2 (3.0) | 1 | 1 (1.5) | 0 | 0 | 3 | 2 (3.0) |
Data are presented as n and N (%)
AE adverse event, A0.3/BPO2.5 adapalene 0.3%/benzoyl peroxide 2.5% gel